FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Generics Series: Key Trends and Events in the 7 Major Markets

Date Published:
December 19, 2007
Price:
$3,800.00
Source:
Datamonitor

Scope

  • An overview of the generics industry across the 7 major markets.
  • Coverage of regulatory and commercial developments within the generics industry.
  • Analysis of the impact of new events on the key stakeholders.
  • Benchmarking recent generics company acquisitions and divestments.
  • Report
    Highlights

    The
    intensely competitive environment of the generics market is behind the
    wave of consolidations that has resulted in a reshuffle of the top 10
    generics companies globally.

    Competitive
    pressures have forced some generics companies out of the more mature
    markets, while others have adopted novel strategies to survive.

    Several
    of the less mature markets, particularly Japan, in which generic uptake
    has historically been slow, are poised for growth, and as such present
    an attractive prospect for international players.

    More stories about